Patent US4446314A successfully refreshed from Google Patents.
US4446314A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fractionation of heparin
Assignee: Bayer Corp
•
Filing: 1982-09-29
•
Granted: 1984-05-01
•
Expires: 2002-09-29
Abstract
Abstract A lectin-containing, water-insoluble gel matrix with a glycoprotein reversibly bound thereto can be used for fractionating a polysaccharidic substance capable of being separated into components of differing activity by virtue of differing affinity for the glycoprotein. In this manner, heparin can be fractionated into high activity and low activity components.
Inventors
- 👤 Robert E. Jordan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 05:01
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; C07K14/8121; C07K14/8128; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
72 words
A method of fractionating unfractionated heparin into components of differing activity, which comprises - (a) contacting the unfractionated heparin with a composition for fractionating heparin into components of differing activity by virtue of differing affinity for antithrombin which comprises a lectin-containing, water-insoluble gel matrix having reversibly bound thereto antithrombin specific for gradiently binding the components of differing activity in heparin, and (b) selectively separating the components of differing activity from the composition.
Claim 2
Independent Claim
72 words
A method of fractionating unfractionated heparin into components of differing activity, which comprises - (a) contacting the unfractionated heparin with a composition for fractionating heparin into components of differing activity by virtue of differing affinity for antithrombin which comprises a lectin-containing, water-insoluble gel matrix having reversibly bound thereto antithrombin specific for gradiently binding the components of differing activity in heparin, and (b) selectively separating the components of differing activity from the composition.
Claim 3
Dependent Claim
55 words
The method of claim 1 wherein the unbound heparin containing low activity heparin is separated from the matrix by contacting the matrix with an aqueous solution containing a physiologically compatible salt and having an ionic strength sufficient to separate the unbound heparin component but insufficient to separate the high activity heparin component from the matrix.
Claim 4
Dependent Claim
12 words
The method of claim 1 wherein the aqueous solution contains sodium chloride.
Claim 5
Dependent Claim
44 words
The method of claim 1 wherein the high activity heparin component is separated from the matrix by contacting the matrix with an aqueous solution containing a physiologically compatible salt and having an ionic strength sufficient to separate the high activity heparin from the matrix.
References Cited (Backward Citations)
US3842061A
Cited
US4119774A
Cited
US4087415A
Cited
US4301153A
Cited
US4289747A
Cited
US4371515A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-05-01 | 1987-10-31 | 1988-05-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-05-01 | 1991-10-31 | 1992-05-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-05-01 | 1995-10-31 | 1996-05-01 | $7700.00 | Window Closed / Lapsed |